Corning Announces Expanded Portfolio of Serum-free Cell Culture Media

  • Email
  • Print

Latest additions provide specialty solutions for the bioprocess market, enable increased performance and efficiencies

CORNING, N.Y., October 10, 2012 -- Corning Incorporated (NYSE: GLW) today announced the expansion of Mediatech, Inc.’s serum-free product portfolio with the addition of two new cell culture media.

The Corning® Hepatocyte Maintenance Medium and the Corning stemgro® MSC Medium capitalize on the growing global demand for specifically defined, serum-free media. The media can enable lab researchers to save time, reduce costs, and improve performance when conducting highly specialized bioprocess assays for the development of therapeutics, vaccines, diagnostics, and pharmaceuticals.

The Corning Hepatocyte Maintenance Medium is optimized to cultivate primary human hepatocytes, a well-established in vitro model system for studying preclinical drug-induced liver injury (DILI).

The Corning stemgro MSC Medium was designed for the maximum expansion of human mesenchymal stem cells (MSCs) derived from bone marrow, cord blood, or adipose tissue.

“Regulatory requirements, performance, and cost concerns have increasingly led to the development of serum-free media alternatives and their use by researchers worldwide,” said Jason Walsh, business director, Mediatech, Corning Life Sciences. “Our new offerings further expand our portfolio of serum-free media to capitalize on this growing market and focus on our customers’ highly specialized needs.”

Key features and benefits of the Corning Hepatocyte Maintenance Medium include:

  • Superior cell health and morphology as they are maintained
  • Animal- and serum-free; chemically defined
  • Ready-to-use media; does not require thawing or addition of frozen supplements

Key features and benefits of the Corning stemgro MSC Medium include:

  • Ability to grow more cells faster
  • Animal- and xeno-free; chemically defined
  • Saves time and money because no plate-coating is necessary if used with Corning CellBIND® surface tissue culture vessels

Corning Life Sciences continually brings new and innovative laboratory technologies to researchers worldwide and helps customers succeed by providing innovative, high-quality products and services in the areas of polymer science, biochemistry and molecular biology, glass melting and forming, surface modification, and characterization science. To learn more about the Hepatocyte Maintenance Medium, the stemgro MSC Medium, or any other Mediatech or Corning Life Sciences products, please contact a customer service representative at 1-800-492-1110, toll free in the United States; (+1) 978-442-2200 internationally; or visit www.corning.com/lifesciences.

Forward-Looking and Cautionary Statements

This press release contains “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning’s financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the effect of global political, economic and business conditions; conditions in the financial and credit markets; currency fluctuations; tax rates; product demand and industry capacity; competition; reliance on a concentrated customer base; manufacturing efficiencies; cost reductions; availability of critical components and materials; new product commercialization; pricing fluctuations and changes in the mix of sales between premium and non-premium products; new plant start-up or restructuring costs; possible disruption in commercial activities due to terrorist activity, armed conflict, political or financial instability, natural disasters, adverse weather conditions, or major health concerns; adequacy of insurance; equity company activities; acquisition and divestiture activities; the level of excess or obsolete inventory; the rate of technology change; the ability to enforce patents; product and components performance issues; retention of key personnel; stock price fluctuations; and adverse litigation or regulatory developments. These and other risk factors are detailed in Corning’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.

About Corning Incorporated

Corning Incorporated (www.corning.com) is the world leader in specialty glass and ceramics. Drawing on more than 160 years of materials science and process engineering knowledge, Corning creates and makes keystone components that enable high-technology systems for consumer electronics, mobile emissions control, telecommunications and life sciences. Our products include glass substrates for LCD televisions, computer monitors and laptops; ceramic substrates and filters for mobile emission control systems; optical fiber, cable, hardware & equipment for telecommunications networks; optical biosensors for drug discovery; and other advanced optics and specialty glass solutions for a number of industries including semiconductor, aerospace, defense, astronomy, and metrology.

Media Relations Contact – United States:
Joseph M. Dunning
(607) 974-5006
dunningjm@corning.com